Impatient Health

Talking to people is hard in 2024. Getting a message across can be ever harder. The reason for this, paradoxically, is because it’s easier than ever. Find out how in our upcoming webinar.

Remember when the latest tech in HCP engagement was an excel sheet, a cold call and a pit-bull of a boss? Those days are as ancient as an ivory abacus. Today, AI avatars are giving field teams a serious upgrade—less abacus, more quantum computer. If you’re curious about how AI is rewriting the rulebook on engagement, our upcoming webinar will dive into the details, with insights from experts who know the game has changed: Dilruwan Chaminda Herath;Francisco Javier Fillat Espuña; Scott Martin; Catherine Best; John Berrios Don’t get left behind. Sign up here: https://lnkd.in/gcNjBi_G

🚀 Is inefficient MLR draining your resources and compromising your objectives? Join Impatient Health’s webinar, "The Real Cost of MLR,” delving into strategies to improve efficiency and maximize the value of MLR processes. Jimmie Overton, one of Canopy’s Medical Affairs experts, will be part of Impatient Health’s panel of industry experts discussing: ✅ New data revealing MLR’s true impact on organizational function ✅ Challenges of scaling to manage increasing content volume and complexity ✅ Strategies to structure, optimize, and elevate Medical’s contribution to the MLR team You’ll gain insights into: • Effective ways to structure and amplify Medical’s role within MLR • Solutions that enable your team to focus on core strategic objectives • Scalable approaches to enhance the efficiency and impact of the medical review process Don’t miss this opportunity to uncover hidden truths about MLR and take steps toward a more impactful approach. 📅 Thursday October 31st, 2024 3:00pm London / 4:00pm Paris / 11:00am New York/ 8:00am San Francisco ⏱️1 hour 🖥️ Zoom Register now: https://bit.ly/3UkvnHM #MedicalAffairs #MLR #Pharmaceuticals #Biotech #ImpatientHealth

Two or three years ago, we were still making the case for omnichannel. In 2024, that argument has been won, and most departments have fledgling programs. That’s not to say the picture is entirely rosy. Part of the reluctance of marketers to try omnichannel in the first place is because they sound too complex, no matter the returns. In 2024, many are starting to see their qualms were misplaced. In one of our upcoming webinars, Paul Simms will be showing you how to simplify your omnichannel operations to bring them to the next level. Sign up and learn more here: https://lnkd.in/e__D9N98

MLR is expensive. Really expensive. Not just because of the time taken to review, revise and approve materials. But also the opportunity cost. The hours it sucks out of a senior leader's time, when they have management and strategy tasks And you might think it’s not senior leaders - but you’re wrong. New research shows that it’s increasingly senior Medical Directors who are dragged into basic review tasks. A few people are managing to turn the corner. See how happy they look? Jimmie Overton; Moulakshi R.; David Tang; Carlos Eid, MD You may not have heard the words ‘smooth’, ‘easy’ and ‘MLR’ in the same sentence before. If that’s a sentence you’d very much like to hear, sign up to this webinar: https://lnkd.in/eHKPA8K6

HCPs don’t know what they’re doing. Wait! Let us explain. We often think of HCP journeys as a series of linear, easy-as-ABC steps, when in truth they are a web of complex interactions that are subject to frequent flux—most of the time, not even the HCPs themselves know how they got to their decisions! But, by closely following HCPs and picking through the digital droppings they leave behind, we can build up a much better understanding of HCP motivations, which in turn allows us to build much better engagement strategies. Sounds hard, but this panel is doing it: Pierre Metrailler; Lin Lei; Graham Addison; Andreas Gerloff; Paul Simms Sign up to our upcoming webinar here: https://lnkd.in/eXqtiBwy

Let's face it. Most Pharma conferences suck. That is what sparked us to start Pharmageddon. Since it's first launch in 2023 we have always tried to "1 up" ourselves by providing a balance between disruptive, informative and accessible (and our competitors have been taking notes 👀) . From our diverse and talented panellist discussions / fireside chats to our engaging and lively Solve sessions. We all have yet again proactively pushed the needle against the grain in order to spark a pharmalution. Thanks to everyone who has attended #Pharmageddon #Europe and supports our mission statement. Whether from the beginning or just recently, we wouldn't be here without you. oh... and if you are interested in joining a community of likeminded industry disruptors. Watch this space.

People buy people. It’s always been the case, and AI isn’t about to change it. But tip top teams in pharma are boosting their people power with real-time AI insights in rep and MSL calls, bringing the performance level of their hires higher and higher.   Our upcoming webinar, ‘Enhanced Engagement’, will show you how. Sign up and learn more here: https://lnkd.in/eCbKmwrF

We honestly cannot be prouder of our incredible and dynamic team who spent 7 months putting this together. The hard work paid off, and it could not have been done without our wonderful and evocative panellists, the amazing people who worked behind the scenes to bring this vision to life, and finally, you!* They say there is another #Pharmageddon in the pipeline, but let's keep that a secret for now. 🤫 *everyone who attended

Have you ever heard of an efficient MLR process? One that is centralized, optimized, digitized, extrernalized and…. works? Me neither. But then, you haven’t been to our next webinar yet. If you’re looking to update your MLR processes and shed the bureaucratic weight of top-down reviews, come along to our upcoming webinar. Sign up here: https://lnkd.in/eHKPA8K6